[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Alnylam Pharmaceuticals, Inc. (ALNY)
Alnylam Pharmaceuticals (ALNY) is seeing a surge in positive sentiment driven by positive clinical data and analyst support. The stock is trending upwards, with analysts predicting further gains based on Elliott Wave analysis.
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on RNA interference (RNAi) therapeutics.
Alnylam Pharmaceuticals, Inc. uses the ticker $ALNY for trading. Listed in the Stocks and category within the Healthcare sectors.
Insights #
- Alnylam Pharmaceuticals, Inc. (ALNY) social dominance near a 52-week low at XXXXX.
- Alnylam Pharmaceuticals, Inc. (ALNY) trading volume is up XX% from the previous year.
- Alnylam Pharmaceuticals, Inc. (ALNY) social dominance is up XXXXX% from the previous week.
- Alnylam Pharmaceuticals, Inc. (ALNY) galaxy score™ is up XXXXX% from the previous week.
- Alnylam Pharmaceuticals, Inc. (ALNY) sentiment is up XX% from the previous week.
Price: $XXXXXX #
Price 24-Hour Chart Data
The stock price is likely increasing due to positive clinical data, regulatory approvals, analyst upgrades, and increased social engagement and mentions. Sentiment is near a 52-week high, and the market cap is up XX% in the last year.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| XXXX% | XXXX% | XXXX% |
1-Year High: $XXXXXX on 2025-07-03
1-Year Low: $XXXXXX on 2025-04-08
AltRank: XXX #
AltRank 24-Hour Chart Data
Alnylam Pharmaceuticals, Inc. (ALNY) is currently AltRank #253 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXX -XXX
1 Month: XXX +85
6 Months: XXX -XXX
1 Year: XXX -XXX
1-Year High: XXXXX on 2025-06-26
1-Year Low: X on 2025-03-22
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +10
1 Month: XX -X
6 Months: XX -X
1 Year: XX -X
1-Year High: XX on 2025-02-19
1-Year Low: XX on 2025-06-26
Engagements: XXXXX #
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX -XX%
6 Months: XXXXXXXXX -XX%
1 Year: XXXXXXXXX -XXXX%
1-Year High: XXXXXXX on 2024-08-31
1-Year Low: XXXXX on 2025-03-14
| Social Network | X | |
|---|---|---|
| Engagements | XXXXX | X |
Mentions: XX #
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XXX
1 Week: XXX -XXXX%
1 Month: XXXXX -XXXX%
6 Months: XXXXX -XXXX%
1 Year: XXXXX +9.10%
1-Year High: XXX on 2024-08-04
1-Year Low: XX on 2025-01-27
| Social Network | X | |
|---|---|---|
| Mentions | XXX | X |
Creators: XX #
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning Alnylam Pharmaceuticals, Inc. (ALNY) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Week: XXX -XX%
1 Month: XXX +12%
6 Months: XXXXX +36%
1 Year: XXXXX +72%
1-Year High: XXX on 2025-06-30
1-Year Low: XX on 2025-01-27
The most influential creators that mention Alnylam Pharmaceuticals, Inc. in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @dub_k1 | X | XXXXX | X | XXX |
Sentiment: XXX% #
Sentiment 24-Hour Chart Data
Current Value: XXX%
Daily Average: XX%
1 Week: XXX% +18%
1 Month: XXX% +6%
6 Months: XXX% +49%
1 Year: XXX% +15%
1-Year High: XXX% on 2025-07-11
1-Year Low: XX% on 2025-03-17
Most Supportive Themes
- Positive Clinical Data, Approvals and Analyst Support: (9%) Recent approval of AMVUTTRA, positive Q1 results, and data from the HELIOS-B Phase X study are boosting investor confidence, alongside positive ratings.
Most Critical Themes
- Competition and Valuation Concerns: (2%) Some users are questioning the efficacy and comparative results of Alnylam's treatments and there are valuation concerns.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXXXX | XX% | X | X% |
| X | X% | X | X% | X | X% | |
| Total | XXXXX | XX% | XXXXX | XX% | X | X% |
Social Dominance: XXXXXXX% #
Social Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% +0.00136%
1 Month: XXXXX% -XXXXX%
6 Months: XXXXX% -XXXXX%
1 Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2024-08-31
1-Year Low: XXXXX% on 2025-07-15
Market Dominance: XXXXX% #
Market Dominance 24-Hour Chart Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXX% on 2024-08-05
1-Year Low: XXXXX% on 2025-07-29
Market Cap: $XXXXXXXXXXXXXX #
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXXX +$1.60%
1 Month: $XXXXXXXXXXXXXX +$2.40%
6 Months: $XXXXXXXXXXXXXX +$21%
1 Year: $XXXXXXXXXXXXXX +$42%
1-Year High: $XXXXXXXXXXXXXX on 2025-07-03
1-Year Low: $XXXXXXXXXXXXXX on 2025-04-08
Top assets mentioned In the posts about Alnylam Pharmaceuticals, Inc. in the last XX hours
Alnylam Pharmaceuticals, Inc. (ALNY) BridgeBio Pharma, Inc. Common Stock (BBIO) Sarepta Therapeutics, Inc. (SRPT) Bitcoin Incognito (XBI) Vertex Protocol (VRTX) United Therapeutics, Corp. (UTHR) Neurocrine Biosciences, Inc. (NBIX) Trade Desk, Inc. (TTD) Zoom Video Communications Inc (ZM)
Top topics mentioned In the posts about Alnylam Pharmaceuticals, Inc. in the last XX hours
stocks healthcare, $bbio, stocks, vrtx, bntx, $srpt, manat, coins healthcare, cah, ebay, hood, $xbi, akro, jnj, $qure, tem, market cap, $vrtx, $uthr, $nbix, $ttd, $zm, $pfe, sarepta therapeutics inc, $prme, hum, stockmarket, arwr, stx, cls, amgn, $vrna, $ntla, $jnj, $asnd, $regn, joby, drugs, moh, rad, alt, $wve, arlo, ait, $burl, $stx, $nvs, loop, $rare, qqq, spx, $rnaz, $akro, $20b, $4b, pltr, investment, $ntla2001, $pg, $alxn, $arwr, $300m, owl, stocks technology, united states, $rckt, espr, idia, $rzlt, $bldr, microsoft corp, eq, egyptian pound, tax bracket, pfe, agx, $tdup, $tecx, gme, asml, ash, crcl, $adsk, smci, stt, vrt, pdsb, repl, $ms, acquisition, $abvx, $mdgl, $prqr, insp, $entb, sny, ibkr, $baynsg, pgen, $hrmy
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$GIL $CRSP $LRCX $BWIN $EXE $FWRD $GLW $SRPT $BURL $NKTR $HII $RTX $BRO $CMG $EIX $CBRE $GRMN $PGY $POWL $PII $DOW $SEI $WCC $SATS $TXT $WHR $LSTR $PRG $BTCI $MP $NTES $EXEL $EMR $ABVX $HTOO $MOD $ERJ $NVDA $TOST $ALNY $PGR $EHC"
@buht on X 2025-07-29 20:29:54 UTC XXX followers, XXX engagements
"Earned $36900 thanks to trades in $SLRX $DRRX & $STAI. @SittemaToms free advice works 📊 $BIIB $REGN $LLY $MRNA $BNTX $PFE $GILD $AMGN $VRTX $SAGE $NBIX $ALNY $CRSP $BLUE $DNA $XBI $IBB $SRPT $MDGL $ICPT"
@sijimi_0125 on X 2025-07-29 15:19:21 UTC XX followers, XXX engagements
"$ACIW $ADNT $AEIS $AFL $AGCO $AGL $AIRC $AIT $ALKS $ALNY $AMED $AMP $AMRX $ANDE $ARLO $ARWR $ASH $ATKR $ATI $AVNT $BHE $BDC $BG $BJ $BLDR $BLKB $BOH $BRC $BSX $BURL"
@Zahra30721 on X 2025-07-29 12:36:06 UTC XXX followers, XXX engagements
"20250728-UBS-US Biotechnology ALNYBBIO 2Q Expectations Too high or not high enough Our math & why .pdf #BioExpect $ALNY $BBIO $REGN $ARGX $VRTX 20250728-UBS-US Aerospace & DefenseFrom A to D earnings recap and readthroughs.pdf #AeroEarn $LMT $RTX $BA $GD $NOC 20250728-UBS-TMT Online ObServerVTEX cross reads from Shopify's Enterprise Opportunity.pdf #TMTObs $VTEX $SHOP $BIGC $SQSP $WIX 20250728-UBS-The Financial EspressoBTG acquires HSBC Uruguay MELI's streaming audience E_commerce.pdf #FinEsp $MELI $HSBC $ITUB $BBD $BSBR 20250728-UBS-Philippine Property SectorAPAC FocusResidential risks"
@WhatMarketMind on X 2025-07-29 02:52:42 UTC 1108 followers, XXX engagements